Adient's revenue has stabilized near $3.9B per quarter with modest 5.0% YoY growth in Q3 2026, but gross margins remain trapped at 6.0%, reflecting a pass-through cost structure with limited pricing power. Operating leverage has failed to materialize, with ope...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $0.48-14.7% vs $0.56 | $3.9B+5.9% vs $3.7B |
Q2 2026 May 6, 2026 | $0.52+40.5% vs $0.37 | $3.9B+6.9% vs $3.6B |
Q1 2026 Feb 4, 2026 | $0.35+90.2% vs $0.18 | $3.6B+5.2% vs $3.5B |
Q4 2025 Nov 5, 2025 | $0.52-5.5% vs $0.55 | $3.7B+4.6% vs $3.5B |
Peter Carlin steps down from Adient board of directors, joins company as CFO on Nov. 16, 2026PR NewswirePLYMOUTH, Mich., Sept. 18, 2026PLYMOUTH, Mich., Sept. 18
PLYMOUTH, Mich., Sept. 18, 2026 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, today announced that on Oct. 1, 2026, Peter Carlin will be stepping down from Adient's board of directors and joining the company initially as vice president, finance.
Adient (NYSE: ADNT - Get Free Report)'s share price gapped up before the market opened on Tuesday after JPMorgan Chase and Co. upgraded the stock from a neutral rating to an overweight rating. The stock had previously closed at $18.76, but opened at $19.30. JPMorgan Chase and Co. now has a $25.00 price target on the
Adient (ADNT) reported earnings 30 days ago. What's next for the stock?
Benchmark ADNT against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Adient plc (ADNT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $17.88 | $1.4B | -5.27 | -1.04% | -1.93% | -11.98% | — | |
| $121.69 | $6.16B | 14.93 | -0.19% | 2.35% | 10.57% | — | |
| $93.03 | $2.48B | 12.78 | -2.53% | 4% | 9.23% | — | |
| $45.17 | $9.56B | 60.23 | 3.47% | 1.17% | 2.36% | — | |
| $63.73 | $17.35B | 21.31 | -0.21% | 1.77% | 5.98% | — | |
| $60.55 | $12.42B | 47.30 | 1.65% | 2.89% | 7.15% | — |
Adient plc (ADNT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Adient plc (ADNT) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 5, 2026·SEC
Jul 10, 2026·SEC
May 20, 2026·SEC
Get notified when ADNT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Adient plc (ADNT) stock FAQ — growth, dividends, profitability & financials explained
Adient plc (ADNT) reported $15.13B in revenue for fiscal year 2025. This represents a 31% decrease from $22.04B in 2014.
Adient plc (ADNT) saw revenue decline by 1.0% over the past year.
Yes, Adient plc (ADNT) is profitable, generating $48.0M in net income for fiscal year 2025 (-1.9% net margin).
Adient plc (ADNT) has a return on equity (ROE) of -12.0%. Negative ROE indicates the company is unprofitable.
Adient plc (ADNT) generated $301.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
